Parliament adopted its recommendations on Thursday for a coordinated EU response to health threats posed by antimicrobial resistance. In a resolution passed with 525 votes in favour, two against and 33 abstentions, MEPs say the successful tackling of antimicrobial resistance (AMR) requires the prudent use of antibiotics for humans and animals, good infection prevention and […]
Read More
Commission secures agreement with BioNTech-Pfizer on the delivery of COVID-19 vaccines
The European Commission, acting with and on behalf of EU Member States through the Health Emergency Preparedness and Response Authority (HERA), and vaccine developers BioNTech-Pfizer, have reached an agreement to better address Member States’ assessment of evolving needs for COVID-19 vaccines. The amendment to the existing vaccines supply contract takes into account the improved epidemiological […]
Read More
Statement by President von der Leyen following the end of the COVID-19 pandemic
Welcoming the WHO’s announcement that COVID-19 no longer constitutes a global health emergency, President Ursula von der Leyen made the following statement: “Finally, after more than 3 years, COVID-19 is no longer a global health emergency. This is good news. This pandemic has had a heavy toll on people, our society and our economy. But we have […]
Read More
SOLUS project: new diagnostic method for breast cancer funded by European funds
At the end of the SOLUS project in October 2021, his team developed a complete operating system for multimodality imaging and a compact device that could serve as the basis for a portable device that can monitor and diagnose critical tissues. Two years later, ongoing efforts at SOLUS may reduce the number of unnecessary breast […]
Read More
Eurostat says older people are healthier in cities
Urban social and environmental factors appear to have a significant impact on how well the population is doing. At the EU level in 2021, 43% of city-dwelling adults 65 and older reported having a very or very good health status, which was 2 percentage points (pp) higher than the national average for all individuals in […]
Read More
Autumn vaccination campaigns targeting the elderly and other high-risk groups will be key to reducing the impact of COVID-19
According to ECDC surveillance data, with every new wave of COVID-19 infection, individuals in older age groups are more likely to be hospitalised. Data suggest persisting SARS-CoV-2 transmission in EU/EEA countries and therefore, a continuous risk of severe disease for vulnerable groups. Although no clear seasonal pattern of virus circulation has emerged so far, data […]
Read More
Mental health didn’t get worse during the pandemic, says large-scale study
During the COVID-19 pandemic, academia and media outlets reported that our mental health had declined. But could this be misleading? A major study on COVID-19 mental health has some surprising findings. Led by Canada’s McGill University, research published in the journal ‘BMJ’ shows that the global pandemic had limited impact on mental health. The power […]
Read More
EU-funded project aims to develop a vaccine against metastatic cells
Clinical trials of a new prototype vaccine designed to selectively target and eradicate the early spread of cancer cells represent another step in the fight against cancer. While most cancer treatments focus on treating the primary tumour, the leading cause of cancer death is metastasis, the spread of cancer cells from the primary tumour to […]
Read More
Researchers have identified antibodies that could defeat all coronaviruses
Researchers have identified antibodies that not only block infection with the latest variant of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), but are also effective against future coronaviruses. With the evolution of SARS-CoV-2, the efficacy of vaccines and antibodies is reduced in the laboratory. So how can a treatment be developed that resists virus […]
Read More